Khadija Saeed

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck stock in focus as MRK lifts $70 billion mid-2030s target and points past Keytruda

Merck & Co boosted its long-term revenue forecast for several new products and pipeline candidates, projecting $70 billion from these “new growth drivers” by the mid-2030s. The company raised its cardiometabolic and respiratory sales outlook to around $20 billion, up from $15 billion, while its infectious-disease forecast jumped to about $15 billion from $5 billion. Merck shares slipped 1.2% to close at $109.19 on Monday. Meanwhile, Johnson & Johnson climbed 2.6%, Eli Lilly added 1.6%, and Pfizer dropped 0.8%.
Synopsys stock rises as CEO flags export curbs, points to March Converge event

Synopsys stock rises as CEO flags export curbs, points to March Converge event

Synopsys ended Monday 1.6% higher at $533.42 as investors digested a shareholder letter from CEO Sassine Ghazi. He highlighted “export restrictions” adding “a measure of uncertainty” to 2025 and flagged “execution challenges.” Ghazi also announced the company will showcase its integrated Synopsys-Ansys platform at a “Synopsys Converge” event in Silicon Valley this March.
13 January 2026
KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA stock notches new 52-week high as chip-tool shares firm; Susquehanna lifts target

KLA Corp shares climbed 2.0% Monday, closing at $1,428.17—a fresh 52-week high that topped the previous peak of $1,406.97 from Jan. 6. Trading volume hit 854,084 shares, below the 50-day average, even as the S&P 500 and Dow finished slightly higher. Applied Materials jumped roughly 2.0%, while Lam Research added nearly 1.0%, boosting the iShares Semiconductor ETF by about 0.5%.
AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

AST SpaceMobile stock in focus after AT&T FirstNet sets first-half 2026 satellite target

AST SpaceMobile’s shares closed Monday up 0.7% at $98.39, following news that AT&T’s FirstNet unit plans to roll out satellite coverage for first responders by mid-2026. “You need a layered approach,” said FirstNet President Scott Agnew. Still, Recon Analytics analyst Roger Entner noted AST is “significantly behind” SpaceX’s Starlink project.
Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

Pfizer stock dips as CEO says obesity-drug cash-pay demand looks “almost like Viagra”

Pfizer Inc. shares fell on Monday after Chief Executive Albert Bourla said the cash-pay market for obesity drugs — where patients pay out of pocket — now works “almost like Viagra”, the erectile-dysfunction drug Pfizer launched in 1998. The company, which bought obesity developer Metsera in a deal valued at up to $10 billion and has said it does not expect to return to revenue growth until 2029, closed down 0.8% at $25.27.
Amphenol stock pops after $10.5B CommScope CCS deal closes — what to watch next

Amphenol stock pops after $10.5B CommScope CCS deal closes — what to watch next

Amphenol Corp shares stayed steady in after-hours Monday following the completion of its $10.5 billion cash deal to acquire CommScope’s Connectivity and Cable Solutions business. Wall Street views the move as a straightforward bet on data-center and network expansion. A regulatory filing noted Amphenol will release financials for the acquired unit and pro forma numbers in a forthcoming amendment.
13 January 2026
1 513 514 515 516 517 893
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 ACCUMULATE

AIG

NYSE: AIG 88 / 100
#5 BUY THE RESET

Ferguson

NYSE: FERG 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.